A Regional Drug and Therapeutics Committee-led Intervention to Reduce the Hospital Costs of Expensive HIV Drugs. [electronic resource]
- Basic & clinical pharmacology & toxicology Sep 2016
- 278-83 p. digital
Publication Type: Journal Article
1742-7843
10.1111/bcpt.12585 doi
Anti-Retroviral Agents--economics Antiretroviral Therapy, Highly Active--economics Drug Costs HIV Infections--drug therapy Hospital Costs Humans Pharmacy and Therapeutics Committee Practice Guidelines as Topic